Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte C Widemann

Showing results (81-90 of 203) with videos related to

Pageof 21
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
A phase I trial and pharmacokinetic study of tipifarnib, a farnesyltransferase inhibitor, and tamoxifen in metastatic breast cancerPeter F Lebowitz, Jennifer Eng-Wong, Brigitte C Widemann, et al.
The Oncologist|July 1, 2008
Characteristics and outcome of pediatric patients enrolled in phase I oncology trialsAerang Kim, Elizabeth Fox, Katherine Warren, et al.
The Oncologist|October 25, 2023
The Landscape of US and Global Rare Tumor Research Programs: A Systematic ReviewChristina Vivelo, Karlyne M Reilly, Brigitte C Widemann, et al.
The Oncologist|February 1, 2023
Outcome of Patients With Malignant Peripheral Nerve Sheath Tumors Enrolled on Sarcoma Alliance for Research Through Collaboration (SARC) Phase II TrialsSrivandana Akshintala, Nicole C Mallory, Yao Lu, et al.
Cancers|December 11, 2022
Demographic and Disease-Related Predictors of Socioemotional Development in Children with Neurofibromatosis Type 1 and Plexiform Neurofibromas: An Exploratory StudyYang Hou, Xian Wu, Dan Liu, et al.
Cancer Chemotherapy and Pharmacology|August 21, 2010
Plasma and CNS pharmacokinetics of O4-benzylfolic acid (O4BF) and metabolite in a non-human primate modelMeredith K Chuk, Diane E Cole, Cynthia McCully, et al.
Cancer Chemotherapy and Pharmacology|July 24, 2017
A phase I/II trial and pharmacokinetic study of mithramycin in children and adults with refractory Ewing sarcoma and EWS-FLI1 fusion transcriptPatrick J Grohar, John Glod, Cody J Peer, et al.
Cancer Discovery|December 10, 2025
Trends in Childhood and Adolescent Cancer Incidence Rates in the United States between 2001 and 2022Meredith S Shiels, Anika T Haque, Rena R Jones, et al.
Pediatric Blood & Cancer|February 15, 2011
Preclincial testing of sorafenib and RAD001 in the Nf(flox/flox) ;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imagingJianqiang Wu, Eva Dombi, Edwin Jousma, et al.
Pediatric Blood & Cancer|September 23, 2010
Phase 1 trial and pharmacokinetic study of the farnesyl transferase inhibitor tipifarnib in children and adolescents with refractory leukemias: a report from the Children's Oncology GroupBrigitte C Widemann, Robert J Arceci, Nalini Jayaprakash, et al.
Pageof 21

Showing results (81-90 of 203) with videos related to

Sort By:
Pageof 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
A phase I trial and pharmacokinetic study of tipifarnib, a farnesyltransferase inhibitor, and tamoxifen in metastatic breast cancerPeter F Lebowitz, Jennifer Eng-Wong, Brigitte C Widemann, et al.
The Oncologist|July 1, 2008
Characteristics and outcome of pediatric patients enrolled in phase I oncology trialsAerang Kim, Elizabeth Fox, Katherine Warren, et al.
The Oncologist|October 25, 2023
The Landscape of US and Global Rare Tumor Research Programs: A Systematic ReviewChristina Vivelo, Karlyne M Reilly, Brigitte C Widemann, et al.
The Oncologist|February 1, 2023
Outcome of Patients With Malignant Peripheral Nerve Sheath Tumors Enrolled on Sarcoma Alliance for Research Through Collaboration (SARC) Phase II TrialsSrivandana Akshintala, Nicole C Mallory, Yao Lu, et al.
Cancers|December 11, 2022
Demographic and Disease-Related Predictors of Socioemotional Development in Children with Neurofibromatosis Type 1 and Plexiform Neurofibromas: An Exploratory StudyYang Hou, Xian Wu, Dan Liu, et al.
Cancer Chemotherapy and Pharmacology|August 21, 2010
Plasma and CNS pharmacokinetics of O4-benzylfolic acid (O4BF) and metabolite in a non-human primate modelMeredith K Chuk, Diane E Cole, Cynthia McCully, et al.
Cancer Chemotherapy and Pharmacology|July 24, 2017
A phase I/II trial and pharmacokinetic study of mithramycin in children and adults with refractory Ewing sarcoma and EWS-FLI1 fusion transcriptPatrick J Grohar, John Glod, Cody J Peer, et al.
Cancer Discovery|December 10, 2025
Trends in Childhood and Adolescent Cancer Incidence Rates in the United States between 2001 and 2022Meredith S Shiels, Anika T Haque, Rena R Jones, et al.
Pediatric Blood & Cancer|February 15, 2011
Preclincial testing of sorafenib and RAD001 in the Nf(flox/flox) ;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imagingJianqiang Wu, Eva Dombi, Edwin Jousma, et al.
Pediatric Blood & Cancer|September 23, 2010
Phase 1 trial and pharmacokinetic study of the farnesyl transferase inhibitor tipifarnib in children and adolescents with refractory leukemias: a report from the Children's Oncology GroupBrigitte C Widemann, Robert J Arceci, Nalini Jayaprakash, et al.
Pageof 21